Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Methapyrilene |
Is a |
True |
Ethylenediamine derivative with histamine receptor antagonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tripelennamine (substance) |
Is a |
True |
Ethylenediamine derivative with histamine receptor antagonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Antazoline (substance) |
Is a |
True |
Ethylenediamine derivative with histamine receptor antagonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mepyramine |
Is a |
False |
Ethylenediamine derivative with histamine receptor antagonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing ethylenediamine derivative and histamine receptor antagonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethylenediamine derivative with histamine receptor antagonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ethylenediamine derivative with histamine receptor antagonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely mepyramine maleate 20 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ethylenediamine derivative with histamine receptor antagonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mepyramine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ethylenediamine derivative with histamine receptor antagonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mepyramine maleate [antihistamine] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ethylenediamine derivative with histamine receptor antagonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mepyramine maleate [nausea] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ethylenediamine derivative with histamine receptor antagonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chlorphenamine- and mepyramine- and phenylephrine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ethylenediamine derivative with histamine receptor antagonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing dexbrompheniramine and mepyramine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ethylenediamine derivative with histamine receptor antagonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chlorphenamine maleate 4 mg and mepyramine maleate 25 mg and phenylephrine hydrochloride 10 mg and phenylpropanolamine 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ethylenediamine derivative with histamine receptor antagonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
pyrilamine maleate+benzocaine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ethylenediamine derivative with histamine receptor antagonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzocaine- and mepyramine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ethylenediamine derivative with histamine receptor antagonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Antazoline sulfate (substance) |
Is a |
True |
Ethylenediamine derivative with histamine receptor antagonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Antazoline hydrochloride |
Is a |
True |
Ethylenediamine derivative with histamine receptor antagonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Antazoline phosphate (substance) |
Is a |
True |
Ethylenediamine derivative with histamine receptor antagonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tripelennamine hydrochloride |
Is a |
True |
Ethylenediamine derivative with histamine receptor antagonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tripelennamine citrate |
Is a |
True |
Ethylenediamine derivative with histamine receptor antagonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|